Loading institutional data...
Loading institutional data...
Held by 608 of 6,047 reporting institutions (97th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-06-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRMB | $6.9B | 118.8× | 11.2× | 1.0× | 29.3% | 30.3% | 0.9% | 2.0% | 0.7% | 4.6× | 376 |
| CELH | $6.8B | 107.7× | 41.6× | 2.7× | 85.5% | 50.4% | 4.3% | 9.1% | 5.8% | 1.6× | 529 |
| PPC | $6.7B | 6.2× | 4.4× | 0.4× | 3.5% | 12.7% | 5.9% | 29.4% | 16.0% | 1.2× | 331 |
| LW | $6.6B | 23.1× | 10.6× | 1.0× | 2.5% | 20.6% | 4.4% | 15.9% | 5.0% | 3.9× | 543 |
| INGR | $5.9B | 8.4× | 5.4× | 0.8× | -2.8% | 25.3% | 10.1% | 17.1% | 12.0% | 0.6× | 589 |
| CPB | $5.6B | 14.4× | 4.9× | 0.6× | -5.0% | 28.1% | 4.1% | 10.5% | 8.3% | 0.5× | 608 |
| POST | $3.2B | 13.2× | 7.9× | 0.4× | 3.0% | 28.7% | 4.1% | 8.9% | 3.0% | 5.5× | 405 |
| FRPT | $3.0B | 24.0× | 17.0× | 2.8× | 13.0% | 40.8% | 12.6% | 11.5% | 11.5% | -1.7× | 313 |
| COCO | $2.9B | 42.6× | 32.7× | 4.8× | 18.2% | 36.5% | 11.7% | 21.5% | 21.5% | -2.4× | 323 |
| TR | $2.8B | — | 22.1× | 3.8× | 1.3% | 35.3% | 13.7% | 10.6% | 10.6% | -1.1× | 227 |
| FIZZ | $2.8B | 15.1× | 9.6× | 2.4× | -1.7% | 37.0% | 15.6% | 28.9% | 28.9% | -1.4× | 253 |
| MZTI | $2.7B | 14.4× | 9.4× | 1.4× | 1.1% | 24.7% | 9.9% | 18.2% | 15.3% | 0.6× | 321 |
| UTZ | $2.1B | — | 27.3× | 1.4× | 2.1% | 24.9% | 0.1% | 0.1% | 0.1% | 7.2× | 227 |
| SAM | $1.7B | 17.0× | 6.4× | 0.9× | -2.4% | 48.5% | 5.5% | 12.8% | 12.8% | -0.9× | 319 |
| JJSF | $1.5B | 23.6× | 8.7× | 0.9× | 0.5% | 29.7% | 4.1% | 6.8% | 6.8% | -0.7× | 244 |
Peers = companies sharing CPB's sector (Food and Kindred Products) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2024, FY2026, FY2027). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $19.37 today, the market must believe free cash flow compounds -3.3%/yr for a decade (off $683.7M on the 3-yr avg basis).
On the basis ($613.0M) the requirement is -1.8%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's -3.3% is in line with its 9-yr track record.
Default is 9.8% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.30B shares (market data) · net debt $583.0M
mean -2.3% · volatility σ 17% · implied rate exceeded in 4/9 yrs
Central path = implied -3.3%/yr growth; shaded band = ±1σ (17%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 69% of free cash flow, leaving room to grow it and fund buybacks. Last year: $470.0M dividends + $26.0M buybacks = $496.0M returned on $678.0M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-08
Is the profit real, and how strong is the balance sheet?
FY2027 · every deduction from revenue to net income
DuPont — the three levers
ROE 10% against ROIC 8% — 2% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 4.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 | FY2027 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 66.8 | 65.5 | 66.8 | 69.3 | 68.8 | 69.2 | 69.6 | 71.9 |
| SG&A | 7.5 | 7.2 | 7.1 | 7.2 | 7.0 | 7.6 | 6.6 | 6.6 |
| Operating Income | 12.1 | 12.7 | 18.2 | 13.6 | 14.0 | 10.4 | 11.0 | 8.7 |
| Income Tax | 1.9 | 2.0 | 3.9 | 2.5 | 2.9 | 2.0 | 1.9 | 1.3 |
| Net Income | 2.6 | 18.7 | 11.8 | 8.8 | 9.2 | 5.9 | 5.9 | 4.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CPB: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $69.0M covers the $0 due within a year 69000000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2021-08-01 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~33.9% on $977.0M of debt.
Cash of $394.0M is below short-term debt of $977.0M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Earns 3.2pts above its cost of capital, but margins are compressing.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2021 | 27.1% | 9.8% (today's — no rate published for this year) | 17.4pts |
| FY2022 | 33.8% | 7.0% | 26.8pts |
| FY2022 | 19.9% | 7.0% | 12.9pts |
| FY2023 | 23.9% | 10.8% | 13.1pts |
| FY2024 | 13.4% | 7.4% | 6.0pts |
| FY2026 | 16.7% | 9.6% | 7.2pts |
| FY2027 | 12.8% | 9.8% (today's — no rate published for this year) | 3.1pts |
| Now | 8.3% | 9.8% | -1.4pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 41.8% | 24.5% | 15.2% |
| FY2018 | 35.9% | 15.3% | 3.9% |
| FY2019 | 33.2% | 12.1% | 2.6% |
| FY2021 | 34.5% | 12.7% | 18.7% |
| FY2022 | 33.2% | 18.2% | 11.8% |
| FY2022 | 30.7% | 13.6% | 8.8% |
| FY2023 | 31.2% | 14.0% | 9.2% |
| FY2024 | 30.8% | 10.4% | 5.9% |
| FY2026 | 30.4% | 11.0% | 5.9% |
| FY2027 | 28.1% | 8.7% | 4.1% |
Leverage and buybacks account for 2 points of the 10% return on equity in FY2027. The business earns 8% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
Margins have compressed 3 years running even as the spread stayed positive.
Converts 1.23x of reported profit into cash — adequate, without much margin.
The cash conversion cycle has lengthened +13 days over 3 years to 32 — that many more days of the company's own cash funding the same volume of business.
Stressed coverage of 1.8x sits between comfortable and thin.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.57x |
| 5% | 2.45x |
| 10% | 2.32x |
| 15% | 2.19x |
| 20% | 2.06x |
| 25% | 1.93x |
| 30% | 1.80x |
| 35% | 1.67x |
| 40% | 1.54x |
| 45% | 1.42x |
| 50% | 1.29x |
| 55% | 1.16x |
| 60% | 1.03x |
This schedule comes from a filing dated 2021-08-01, 1895 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2021-08-01 (10-K); cash from the 2021-08-01 balance sheet; FCF from FY2022.
Balance sheet at 2021-08-01. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $18.90, free cash flow must compound -2.75%/yr for 10 years. It has done -7.71%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2022 | −30.7% | −2.7% |
| FY2022 | 23.6% | −2.7% |
| FY2023 | −17.7% | −2.7% |
| FY2024 | −13.6% | −2.7% |
| FY2026 | 5.5% | −2.7% |
| FY2027 | −3.8% | −2.7% |
The implied rate has been matched or beaten in 2 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $403M | $403M |
| Share-based comp | $56M | $459M |
| Other non-cash & working capital | $580M | $1.04B |
| Operating cash flow | $1.04B | $1.04B |
| Capex | −$361M | $678M |
| Free cash flow | $678M | $678M |
| FCF after SBC | $622M | $622M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2022 | -2.5% | 2.6% | 5.1 points |
| FY2022 | 1.0% | -9.9% | -10.9 points |
| FY2023 | 9.3% | 0.8% | -8.5 points |
| FY2024 | 3.0% | 18.8% | 15.8 points |
| FY2026 | 6.4% | -7.8% | -14.2 points |
| FY2027 | -5.0% | -4.4% | 0.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2021 | 22.3 days | 55.9 days | 67.3 days | 10.8 days |
| FY2022 | 23.4 days | 60.1 days | 68.9 days | 14.6 days |
| FY2022 | 20.9 days | 76.6 days | 82 days | 15.5 days |
| FY2023 | 19.3 days | 73.2 days | 74 days | 18.4 days |
| FY2024 | 22.2 days | 75.9 days | 71.8 days | 26.3 days |
| FY2026 | 19.3 days | 72.9 days | 68.1 days | 24 days |
| FY2027 | 19.4 days | 84 days | 71.8 days | 31.6 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2021 | 1.9 percent |
| FY2022 | -0.3 percent |
| FY2022 | -3.6 percent |
| FY2023 | -2.4 percent |
| FY2024 | -4.1 percent |
| FY2026 | -3.5 percent |
| FY2027 | -4.1 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2027) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
EOD close · as of 2026-10-08
How a revenue dollar becomes profit — FY2027
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2027 | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.74B 100.0% | $10.25B 100.0% | $9.64B 100.0% | $9.36B 100.0% | $8.56B 100.0% | $8.48B 100.0% | $8.69B 100.0% | $8.11B 100.0% | $6.62B 100.0% | $5.84B 100.0% |
| Cost of Revenue | $7.00B 71.9% | $7.13B 69.6% | $6.67B 69.2% | $6.44B 68.8% | $5.93B 69.3% | $5.67B 66.8% | $5.69B 65.5% | $5.41B 66.8% | $4.24B 64.1% | $3.40B 58.2% |
| Cost of Products | — | — | — | — | — | — | — | — | $5.87B 88.7% | $4.96B 85.1% |
| Selling, General & Admin | $646.0M 6.6% | $674.0M 6.6% | $737.0M 7.6% | $654.0M 7.0% | $617.0M 7.2% | $598.0M 7.1% | $622.0M 7.2% | $610.0M 7.5% | $563.0M 8.5% | $448.0M 7.7% |
| Total Operating Expenses | $8.89B 91.3% | $9.13B 89.0% | $8.64B 89.6% | $8.04B 86.0% | $7.40B 86.4% | $6.93B 81.8% | $7.58B 87.3% | $7.13B 87.9% | $5.61B 84.7% | $4.41B 75.5% |
| Operating Income | $852.0M 8.7% | $1.12B 11.0% | $1.00B 10.4% | $1.31B 14.0% | $1.16B 13.6% | $1.54B 18.2% | $1.11B 12.7% | $979.0M 12.1% | $1.01B 15.3% | $1.43B 24.5% |
| Interest Expense | $331.0M 3.4% | $345.0M 3.4% | $249.0M 2.6% | $188.0M 2.0% | $189.0M 2.2% | $210.0M 2.5% | $345.0M 4.0% | $356.0M 4.4% | $183.0M 2.8% | $115.0M 2.0% |
| Interest & Investment Income | $8.0M 0.1% | $17.0M 0.2% | $6.0M 0.1% | $4.0M 0.0% | $1.0M 0.0% | $1.0M 0.0% | $4.0M 0.0% | $2.0M 0.0% | $3.0M 0.0% | $0 0.0% |
| Other Income (Expense), net | -$171.0M -1.8% | -$273.0M -2.7% | -$261.0M -2.7% | -$32.0M -0.3% | -$21.0M -0.2% | $254.0M 3.0% | -$221.0M -2.5% | -$140.0M -1.7% | $73.0M 1.1% | $216.0M 3.7% |
| Pretax Income | $529.0M 5.4% | $796.0M 7.8% | $757.0M 7.9% | $1.13B 12.1% | $975.0M 11.4% | $1.34B 15.8% | $766.0M 8.8% | $625.0M 7.7% | $830.0M 12.5% | $1.32B 22.5% |
| Income Tax Expense | $124.0M 1.3% | $194.0M 1.9% | $190.0M 2.0% | $270.0M 2.9% | $218.0M 2.5% | $328.0M 3.9% | $174.0M 2.0% | $151.0M 1.9% | $106.0M 1.6% | $392.0M 6.7% |
| Net Income | $403.0M 4.1% | $602.0M 5.9% | $567.0M 5.9% | $858.0M 9.2% | $757.0M 8.8% | $1.00B 11.8% | $1.63B 18.7% | $211.0M 2.6% | $261.0M 3.9% | $887.0M 15.2% |
| Per Share | ||||||||||
| EPS (Basic) | $1.34 | $2.02 | $1.90 | $2.87 | $2.51 | $3.31 | $5.39 | $0.70 | $0.87 | $2.91 |
| EPS (Diluted) | $1.31 | $2.01 | $1.89 | $2.85 | $2.51 | $3.29 | $5.36 | $0.70 | $0.86 | $2.89 |
| Weighted Avg Shares (Basic) | 298.0M | 298.0M | 298.0M | 299.0M | 301.0M | 303.0M | 302.0M | 301.0M | 301.0M | 305.0M |
| Weighted Avg Shares (Diluted) | 300.0M | 300.0M | 300.0M | 301.0M | 302.0M | 305.0M | 304.0M | 302.0M | 302.0M | 307.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.